1988
DOI: 10.1097/00005344-198805000-00007
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic Antagonist

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
131
0
3

Year Published

1997
1997
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 195 publications
(138 citation statements)
references
References 0 publications
4
131
0
3
Order By: Relevance
“…[6][7][8] Consequently, currently available b-blockers represent a highly heterogeneous class, differentiated by their pharmacologic effects on b 1 -specificity, peripheral vascular resistance, cardiac output, metabolic profile and overall tolerability. [6][7][8] Nebivolol is a selective b 1 -adrenoreceptor blocker 9 that possesses vasodilatory properties. [10][11][12][13] Nebivolol possesses a distinct hemodynamic profile, including reduced peripheral vascular resistance and neutral impact on cardiac output.…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8] Consequently, currently available b-blockers represent a highly heterogeneous class, differentiated by their pharmacologic effects on b 1 -specificity, peripheral vascular resistance, cardiac output, metabolic profile and overall tolerability. [6][7][8] Nebivolol is a selective b 1 -adrenoreceptor blocker 9 that possesses vasodilatory properties. [10][11][12][13] Nebivolol possesses a distinct hemodynamic profile, including reduced peripheral vascular resistance and neutral impact on cardiac output.…”
Section: Introductionmentioning
confidence: 99%
“…Exclusion metic activity. 1,2 It has been shown to control blood criteria are listed in Table 1. pressure (BP) over 24 h with dosage once daily.…”
Section: Introductionmentioning
confidence: 99%
“…23,24 It lowers blood pressure by reducing peripheral vascular resistance, and significantly increases stroke volume with preservation of cardiac output. [16][17][18] The net hemodynamic effect of nebivolol is the result of a balance between the depressant effects of beta blockade and an action that maintains cardiac output. It is thought that the anti-oxidative and nitric oxide-mediated mechanisms of action observed in nebivolol may be beneficial in reducing the progression of insulin resistance, diabetes mellitus and cardiovascular diseases.…”
Section: Discussionmentioning
confidence: 99%
“…Nebivolol is a highly cardioselective vasodilatory beta 1 receptor blocker that lowers blood pressure (BP) by reducing peripheral vascular resistance, and significantly increases stroke volume with preservation of cardiac output when compared with atenolol, another beta 1 receptor blocker. [16][17][18] Methods Subjects Obese African-American men and women between the ages of 18 and 75 years (mean age 50 years) with recently diagnosed Stage 1 hypertension were enrolled in the study. Obesity was defined as body mass index 430.…”
Section: Introductionmentioning
confidence: 99%